SG Americas Securities’s Thermo Fisher Scientific TMO Stock Holding History

SG Americas Securities’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$693K	Buy	11,100 +6,200	+127%	+$3.36M	﹤0.01%	1989
2025 Q4	$135K	Hold	4,900	–	–	﹤0.01%	3098
2025 Q3	$230K	Hold	4,900	–	–	﹤0.01%	2669
2025 Q2	$367K	Buy	+4,900	New	+$2.05M	﹤0.01%	1865
2023 Q4	–	Sell	-8,500	Closed	-$1M	–	3444
2023 Q3	$1M	Hold	8,500	–	–	0.01%	1258
2023 Q2	$876K	Hold	8,500	–	–	0.01%	1118
2023 Q1	$565K	Sell	8,500 -2,400	-22%	-$1.35M	0.01%	1621
2022 Q4	$1.02M	Sell	10,900 -37,500	-77%	-$19.9M	0.01%	963
2022 Q3	$2.38M	Buy	48,400 +37,500	+344%	+$21M	0.03%	507
2022 Q2	$1.11M	Hold	10,900	–	–	0.01%	1215
2022 Q1	$902K	Hold	10,900	–	–	0.01%	1497
2021 Q4	$787K	Buy	+10,900	New	+$6.81M	﹤0.01%	1813
2021 Q1	–	Sell	-20,000	Closed	-$1K	–	3560
2020 Q4	$1K	Hold	20,000	–	–	﹤0.01%	3305
2020 Q3	$28K	Sell	20,000 -50,000	-71%	-$20.7M	﹤0.01%	2550
2020 Q2	$389K	Buy	70,000 +50,000	+250%	+$16.8M	﹤0.01%	2318
2020 Q1	$459K	Sell	20,000 -4,000	-17%	-$1.26M	﹤0.01%	1912
2019 Q4	$185K	Buy	+24,000	New	+$7.28M	﹤0.01%	2536
2019 Q3	–	Sell	-22,500	Closed	-$32K	–	3213
2019 Q2	$32K	Hold	22,500	–	–	﹤0.01%	2963
2019 Q1	$109K	Buy	+22,500	New	+$5.6M	﹤0.01%	3010
2018 Q1	–	Sell	-29,700	Closed	-$5K	–	3547
2017 Q4	$5K	Hold	29,700	–	–	﹤0.01%	3108
2017 Q3	$13K	Buy	29,700 +600	+2%	+$109K	﹤0.01%	3417
2017 Q2	$21K	Hold	29,100	–	–	﹤0.01%	3089
2017 Q1	$66K	Sell	29,100 -89,900	-76%	-$13.7M	﹤0.01%	3076
2016 Q4	$291K	Buy	119,000 +29,100	+32%	+$4.29M	﹤0.01%	2058
2016 Q3	$110K	Hold	89,900	–	–	﹤0.01%	3002
2016 Q2	$372K	Buy	+89,900	New	+$13.3M	﹤0.01%	1849

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SG Americas Securities's TMO Position: Q1 2026 in Review

SG Americas Securities increased its Thermo Fisher Scientific (TMO) stake by 7.6% in Q1 2026, buying an estimated $5.54M and bringing the position to 143,935 shares worth $66.7M. The position accounts for 0.07% of the portfolio, ranked #225.

SG Americas Securities first reported a position in TMO in Q2 2013 and has held it in 51 quarters since. The position peaked at $237M in Q2 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

SG Americas Securities held 143,935 shares of Thermo Fisher Scientific worth $66.7M as of Q1 2026.
SG Americas Securities bought 10,210 Thermo Fisher Scientific shares in Q1 2026, an estimated $5.54M.
Thermo Fisher Scientific made up 0.07% of SG Americas Securities's portfolio in Q1 2026, its #225 holding.
SG Americas Securities first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 51 quarters since.
SG Americas Securities's Thermo Fisher Scientific position peaked at $237M in Q2 2021.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.